Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Theta-burst temporal interference stimulation to improve awareness in people with disorders of consciousness

Official title: Effectiveness of Theta-Burst Patterned Temporal Interference Stimulation for Improving Awareness in Patients With Disorders of Consciousness: A Multicenter Randomized Double-Blind Controlled Trial

Run by Zhujiang Hospital · NCT07539740 · Data updated 2026-11-12

This study will test whether theta-burst patterned temporal interference stimulation (tTIs) can help adults with recent disorders of consciousness (vegetative or minimally conscious) show more signs of awareness.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment136 (estimated)
SponsorZhujiang Hospital
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedMarch 8, 2026
Main results expectedDecember 31, 2027
Study endsMay 31, 2028
Registry record updatedApril 20, 2026
Trial IDNCT07539740 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are right-handed adults age 18–70 with a diagnosis of vegetative/unresponsive wakefulness or minimally conscious state of one year duration or less, who are medically stable, can undergo MRI/EEG, are not on sedative or interfering medications, and have no skull/brain implants or uncontrolled epilepsy.

Probably not a fit

Patients with disease duration over one year, uncontrolled seizures, incompatible implanted devices, prior neuropsychiatric disorders, or who cannot discontinue interfering medications are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind, sham-controlled trial testing tTIs targeted to the centromedian-parafascicular (CM-pf) thalamic complex using MRI-guided placement. Participants receive either active tTIs or a sham procedure twice daily for five consecutive days (30 minutes per session, 10 sessions total) with 2 mA per channel (4 mA total) and theta-burst patterned pulses. Clinical awareness is measured before and after treatment using standardized scales (e.g., Coma Recovery Scale–Revised) and EEG to track changes in brain network function, with continuous safety monitoring. The trial compares active versus sham stimulation to determine whether tTIs produces greater behavioral and electrophysiological signs of improved consciousness.

Why it matters

Potential benefit: If successful, tTIs could noninvasively increase signs of awareness and improve brain network function, offering a new treatment option for people with disorders of consciousness.

How similar studies have gone: Related invasive and noninvasive thalamic stimulation approaches have shown some promising but mixed results in restoring awareness, while theta-burst temporal interference stimulation is a novel technique with limited prior human data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 18 to 70 years old.
* Condition: Patients diagnosed with Disorders of Consciousness (DoC), including Vegetative State (VS)/Unresponsive Wakefulness Syndrome (UWS) or Minimally Conscious State (MCS) according to international guidelines.
* Duration: Disease course ≤ 1 year.Medical History: No history of neuro-psychiatric disorders prior to the brain injury.
* Handedness: Right-handed.Safety: No contraindications for tTIs, EEG, or MRI.
* Medication: Not currently using sedative drugs or medications that interfere with brain stimulation, such as Na2+ or Ca2+ channel blockers, or NMDA receptor antagonists.

Exclusion Criteria:

* Concurrent Trials: Participation in other non-invasive or invasive neuromodulation trials.
* Epilepsy: Uncontrolled epilepsy, defined as a seizure within 4 weeks prior to enrollment.
* Implants: Presence of metal implants in the skull, brain pacemakers, or implanted brain devices (e.g., spinal cord stimulator).
* Structural Issues: Skull defects at the site of stimulation that prevent the implementation of tTIs.
* Systemic Implants: Presence of systemic metal implants, such as cardiac pacemakers.

Where it's running

  • Zhujiang Hospital of Southern Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.